Literature DB >> 23230271

Talin1 and Rap1 are critical for osteoclast function.

Wei Zou1, Takashi Izawa, Tingting Zhu, Jean Chappel, Karel Otero, Susan J Monkley, David R Critchley, Brian G Petrich, Alexei Morozov, Mark H Ginsberg, Steven L Teitelbaum.   

Abstract

To determine talin1's role in osteoclasts, we mated TLN1(fl/fl) mice with those expressing cathepsin K-Cre (CtsK-TLN1) to delete the gene in mature osteoclasts or with lysozyme M-Cre (LysM-TLN1) mice to delete TLN1 in all osteoclast lineage cells. Absence of TLN1 impairs macrophage colony-stimulating factor (M-CSF)-stimulated inside-out integrin activation and cytoskeleton organization in mature osteoclasts. Talin1-deficient precursors normally express osteoclast differentiation markers when exposed to M-CSF and receptor activator of nuclear factor κB (RANK) ligand but attach to substrate and migrate poorly, arresting their development into mature resorptive cells. In keeping with inhibited resorption, CtsK-TLN1 mice exhibit an ∼5-fold increase in bone mass. Osteoclast-specific deletion of Rap1 (CtsK-Rap1), which promotes talin/β integrin recognition, yields similar osteopetrotic mice. The fact that the osteopetrosis of CtsK-TLN1 and CtsK-Rap1 mice is substantially more severe than that of those lacking αvβ3 is likely due to added failed activation of β1 integrins. In keeping with osteoclast dysfunction, mice in whom talin is deleted late in the course of osteoclastogenesis are substantially protected from ovariectomy-induced osteoporosis and the periarticular osteolysis attending inflammatory arthritis. Thus, talin1 and Rap1 are critical for resorptive function, and their selective inhibition in mature osteoclasts retards pathological bone loss.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23230271      PMCID: PMC3571341          DOI: 10.1128/MCB.00790-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.

Authors:  S Takeshita; K Kaji; A Kudo
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

Review 2.  Integrin signaling to the actin cytoskeleton.

Authors:  Kris A DeMali; Krister Wennerberg; Keith Burridge
Journal:  Curr Opin Cell Biol       Date:  2003-10       Impact factor: 8.382

3.  Effect of L-000845704, an alphaVbeta3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.

Authors:  M G Murphy; K Cerchio; S A Stoch; K Gottesdiener; M Wu; R Recker
Journal:  J Clin Endocrinol Metab       Date:  2005-02-01       Impact factor: 5.958

4.  The antithrombotic potential of selective blockade of talin-dependent integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation.

Authors:  Brian G Petrich; Per Fogelstrand; Anthony W Partridge; Nima Yousefi; Ararat J Ablooglu; Sanford J Shattil; Mark H Ginsberg
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 5.  The tail of integrins, talin, and kindlins.

Authors:  Markus Moser; Kyle R Legate; Roy Zent; Reinhard Fässler
Journal:  Science       Date:  2009-05-15       Impact factor: 47.728

6.  Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis.

Authors:  Baohong Zhao; Masamichi Takami; Atsushi Yamada; Xiaogu Wang; Takako Koga; Xiaoyu Hu; Tomohiko Tamura; Keiko Ozato; Yongwon Choi; Lionel B Ivashkiv; Hiroshi Takayanagi; Ryutaro Kamijo
Journal:  Nat Med       Date:  2009-08-30       Impact factor: 53.440

7.  Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.

Authors:  Takashi Nakamura; Yuuki Imai; Takahiro Matsumoto; Shingo Sato; Kazusane Takeuchi; Katsuhide Igarashi; Yoshifumi Harada; Yoshiaki Azuma; Andree Krust; Yoko Yamamoto; Hiroshi Nishina; Shu Takeda; Hiroshi Takayanagi; Daniel Metzger; Jun Kanno; Kunio Takaoka; T John Martin; Pierre Chambon; Shigeaki Kato
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

8.  M-CSF regulates the cytoskeleton via recruitment of a multimeric signaling complex to c-Fms Tyr-559/697/721.

Authors:  Roberta Faccio; Sunao Takeshita; Graziana Colaianni; Jean Chappel; Alberta Zallone; Steven L Teitelbaum; F Patrick Ross
Journal:  J Biol Chem       Date:  2007-04-09       Impact factor: 5.157

9.  Talin depletion reveals independence of initial cell spreading from integrin activation and traction.

Authors:  Xian Zhang; Guoying Jiang; Yunfei Cai; Susan J Monkley; David R Critchley; Michael P Sheetz
Journal:  Nat Cell Biol       Date:  2008-09       Impact factor: 28.824

10.  Talin is required for integrin-mediated platelet function in hemostasis and thrombosis.

Authors:  Brian G Petrich; Patrizia Marchese; Zaverio M Ruggeri; Saskia Spiess; Rachel A M Weichert; Feng Ye; Ralph Tiedt; Radek C Skoda; Susan J Monkley; David R Critchley; Mark H Ginsberg
Journal:  J Exp Med       Date:  2007-12-17       Impact factor: 14.307

View more
  43 in total

1.  Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.

Authors:  Z J Zhai; H W Li; G W Liu; X H Qu; B Tian; W Yan; Z Lin; T T Tang; A Qin; K R Dai
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

2.  Activation of EPAC1/2 is essential for osteoclast formation by modulating NFκB nuclear translocation and actin cytoskeleton rearrangements.

Authors:  Aránzazu Mediero; Miguel Perez-Aso; Bruce N Cronstein
Journal:  FASEB J       Date:  2014-08-13       Impact factor: 5.191

3.  Osteoclastic bone resorption depends on talin 1 and its receptor Rap1.

Authors: 
Journal:  Bonekey Rep       Date:  2013-03-20

Review 4.  Podosome organization drives osteoclast-mediated bone resorption.

Authors:  Dan Georgess; Irma Machuca-Gayet; Anne Blangy; Pierre Jurdic
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

5.  Phospholipase C-related, but catalytically inactive protein (PRIP) up-regulates osteoclast differentiation via calcium-calcineurin-NFATc1 signaling.

Authors:  Ayako Murakami; Miho Matsuda; Yui Harada; Masato Hirata
Journal:  J Biol Chem       Date:  2017-03-24       Impact factor: 5.157

6.  PGC1β Organizes the Osteoclast Cytoskeleton by Mitochondrial Biogenesis and Activation.

Authors:  Yan Zhang; Nidhi Rohatgi; Deborah J Veis; Joel Schilling; Steven L Teitelbaum; Wei Zou
Journal:  J Bone Miner Res       Date:  2018-03-11       Impact factor: 6.741

7.  Targeted Proteomics Guided by Label-free Quantitative Proteome Analysis in Saliva Reveal Transition Signatures from Health to Periodontal Disease.

Authors:  Nagihan Bostanci; Nathalie Selevsek; Witold Wolski; Jonas Grossmann; Kai Bao; Asa Wahlander; Christian Trachsel; Ralph Schlapbach; Veli Özgen Öztürk; Beral Afacan; Gulnur Emingil; Georgios N Belibasakis
Journal:  Mol Cell Proteomics       Date:  2018-04-02       Impact factor: 5.911

8.  Cytosolic proteome profiling of monocytes for male osteoporosis.

Authors:  W Zhu; H Shen; J-G Zhang; L Zhang; Y Zeng; H-L Huang; Y-C Zhao; H He; Y Zhou; K-H Wu; Q Tian; L-J Zhao; F-Y Deng; H-W Deng
Journal:  Osteoporos Int       Date:  2016-11-14       Impact factor: 4.507

9.  Vinculin regulates osteoclast function.

Authors:  Tomohiro Fukunaga; Wei Zou; Julia T Warren; Steven L Teitelbaum
Journal:  J Biol Chem       Date:  2014-03-27       Impact factor: 5.157

10.  Involvement of miR-337 in high glucose-suppressed osteogenic differentiation in bone marrow mesenchymal stem cells via negative regulation of Rap1A.

Authors:  Shuai Liu; Xiaokai Yang; Xiaohuan Zhong; Lei Li; Xiao Zhang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-03-21       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.